Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 02, 2023

SELL
$98.98 - $115.74 $390,179 - $456,247
-3,942 Reduced 24.81%
11,948 $1.38 Million
Q2 2023

Aug 09, 2023

SELL
$96.34 - $112.38 $53,372 - $62,258
-554 Reduced 3.37%
15,890 $1.63 Million
Q1 2023

May 11, 2023

SELL
$107.32 - $113.5 $556,239 - $588,270
-5,183 Reduced 23.97%
16,444 $1.79 Million
Q4 2022

Feb 13, 2023

SELL
$62.39 - $113.8 $5.66 Million - $10.3 Million
-90,657 Reduced 80.74%
21,627 $2.46 Million
Q4 2022

Feb 13, 2023

BUY
$62.39 - $113.8 $5.67 Million - $10.3 Million
90,940 Added 426.07%
112,284 $12.8 Million
Q3 2022

Nov 14, 2022

SELL
$58.92 - $84.67 $1.35 Million - $1.94 Million
-22,969 Reduced 51.83%
21,344 $1.14 Million
Q2 2022

Aug 05, 2022

BUY
$79.4 - $116.36 $1.04 Million - $1.52 Million
13,092 Added 41.93%
44,313 $2.35 Million
Q1 2022

May 09, 2022

BUY
$86.42 - $109.81 $136,284 - $173,170
1,577 Added 5.32%
31,221 $3.29 Million
Q4 2021

Feb 07, 2022

SELL
$98.56 - $119.91 $38,536 - $46,884
-391 Reduced 1.3%
29,644 $3.19 Million
Q3 2021

Oct 28, 2021

SELL
$91.91 - $110.37 $118,931 - $142,818
-1,294 Reduced 4.13%
30,035 $3.29 Million
Q2 2021

Aug 13, 2021

SELL
$86.24 - $95.92 $1,121 - $1,246
-13 Reduced 0.04%
31,329 $2.94 Million
Q1 2021

May 06, 2021

BUY
$71.83 - $95.48 $1.65 Million - $2.19 Million
22,908 Added 271.61%
31,342 $2.89 Million
Q4 2020

Feb 12, 2021

BUY
$67.0 - $84.39 $30,619 - $38,566
457 Added 5.73%
8,434 $616,000
Q3 2020

Nov 06, 2020

BUY
$55.23 - $79.93 $111,122 - $160,819
2,012 Added 33.73%
7,977 $620,000
Q2 2020

Jul 29, 2020

BUY
$30.2 - $56.98 $180,143 - $339,885
5,965 New
5,965 $331,000
Q1 2020

May 14, 2020

SELL
$24.87 - $38.56 $147,603 - $228,853
-5,935 Closed
0 $0
Q4 2019

Feb 07, 2020

BUY
$25.43 - $36.67 $150,927 - $217,636
5,935 New
5,935 $215,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track M&T Bank Corp Portfolio

Follow M&T Bank Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.